Group One Trading
RGNX icon

Group One Trading’s Regenxbio RGNX Stock Holding History

Group One Trading’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$164K Buy
13,660
+11,982
+714% +$99.4K ﹤0.01% 4452
2026
Q1 		$14.1K Buy
1,678
+874
+109% +$9.18K ﹤0.01% 6163
2025
Q4 		$11.6K Buy
+804
New +$10K ﹤0.01% 6725
2025
Q2 		– Sell
-5,566
Closed -$46.6K – 8550
2025
Q1 		$39.8K Buy
+5,566
New +$41.4K ﹤0.01% 5330
2024
Q4 		– Sell
-3,926
Closed -$36.9K – 7847
2024
Q3 		$41.2K Buy
+3,926
New +$47.9K ﹤0.01% 4775
2023
Q1 		– Sell
-2,187
Closed -$48.4K – 7833
2022
Q4 		$49.6K Sell
2,187
-989
-31% -$22.4K ﹤0.01% 4997
2022
Q3 		$84K Buy
3,176
+989
+45% +$29.3K ﹤0.01% 4932
2022
Q2 		$54K Buy
+2,187
New +$54.6K ﹤0.01% 5490
2021
Q4 		– Sell
-1,003
Closed -$34.2K – 8749
2021
Q3 		$42K Buy
1,003
+273
+37% +$9.82K ﹤0.01% 6677
2021
Q2 		$28K Sell
730
-3,170
-81% -$113K ﹤0.01% 6997
2021
Q1 		$133K Sell
3,900
-6,575
-63% -$280K ﹤0.01% 5397
2020
Q4 		$475K Buy
+10,475
New +$366K ﹤0.01% 3307
2020
Q3 		– Sell
-583
Closed -$19K – 6482
2020
Q2 		$21K Sell
583
-13,929
-96% -$519K ﹤0.01% 4810
2020
Q1 		$470K Sell
14,512
-5,520
-28% -$230K ﹤0.01% 2093
2019
Q4 		$821K Buy
20,032
+19,966
+30,252% +$789K 0.01% 2051
2019
Q3 		$2K Sell
66
-39,964
-100% -$1.62M ﹤0.01% 4924
2019
Q2 		$2.06M Buy
40,030
+10,664
+36% +$532K 0.02% 1063
2019
Q1 		$1.68M Sell
29,366
-17,215
-37% -$853K 0.02% 1047
2018
Q4 		$1.95M Buy
46,581
+44,002
+1,706% +$2.58M 0.02% 1054
2018
Q3 		$195K Buy
2,579
+425
+20% +$30.6K ﹤0.01% 3032
2018
Q2 		$155K Buy
2,154
+476
+28% +$22.7K ﹤0.01% 3250
2018
Q1 		$50K Buy
1,678
+1,404
+512% +$40.9K ﹤0.01% 3657
2017
Q4 		$9K Buy
+274
New +$8.26K ﹤0.01% 4413

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Group One Trading's RGNX Position: Q2 2026 in Review

Group One Trading increased its Regenxbio (RGNX) stake by 714% in Q2 2026, buying an estimated $99.4K and bringing the position to 13,660 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #4452.

Group One Trading first reported a position in RGNX in Q4 2017 and has held it in 23 quarters since. The position peaked at $2.06M in Q2 2019. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Group One Trading held 13,660 shares of Regenxbio worth $164K as of Q2 2026.
  • Group One Trading bought 11,982 Regenxbio shares in Q2 2026, an estimated $99.4K.
  • Regenxbio made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #4452 holding.
  • Group One Trading first reported a position in Regenxbio in Q4 2017 and has held it in 23 quarters since.
  • Group One Trading's Regenxbio position peaked at $2.06M in Q2 2019.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.